These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25840739)

  • 1. [Mortality among the sulphonylureas].
    Seguí Díaz M
    Semergen; 2015 Oct; 41(7):393-4. PubMed ID: 25840739
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphonylureas in the treatment of non-insulin-dependent diabetes.
    Ferner RE; Alberti KG
    Q J Med; 1989 Nov; 73(271):987-95. PubMed ID: 2695959
    [No Abstract]   [Full Text] [Related]  

  • 3. Which should we ADOPT: sulphonylureas or glitazones?
    Koshiyama H; Inagaki N; Seino Y
    Diabet Med; 2007 Jul; 24(7):804. PubMed ID: 17596243
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complications.
    Weng J; Yang X
    J Diabetes; 2014 Jan; 6(1):30-2. PubMed ID: 23944992
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease.
    Fasching P
    Diabetologia; 1998 Jun; 41(6):743-4. PubMed ID: 9662063
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of sulphonylureas in the management of type 2 diabetes mellitus.
    Rendell M
    Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of sulphonylureas in the elderly.
    Graal MB; Wolffenbuttel BH
    Drugs Aging; 1999 Dec; 15(6):471-81. PubMed ID: 10641958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risk with sulphonylureas compared to metformin.
    Holden SE; Currie CJ
    Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.
    Tirkkonen T; Heikkilä P; Huupponen R; Laine K
    J Intern Med; 2010 Oct; 268(4):359-66. PubMed ID: 20698928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sulphonylureas on the microvascular and macrovascular complications of diabetes.
    Kar P; Holt RI
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):207-13. PubMed ID: 18288596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
    Scheen AJ
    Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
    Ravina A; Minuhin O
    Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes: Hypoglycaemia risk with dual use of DPP-4 inhibitors and sulphonylureas.
    Holmes D
    Nat Rev Endocrinol; 2016 Jul; 12(7):374. PubMed ID: 27199288
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.
    Iwamoto Y; Kosaka K; Kuzuya T; Akanuma Y; Shigeta Y; Kaneko T
    Diabet Med; 1996 Apr; 13(4):365-70. PubMed ID: 9162613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia in Frail Elderly Patients With Type 2 Diabetes Mellitus Treated With Sulfonylurea.
    van Dijk P; Bouma A; Landman GW; Groenier KH; Bilo H; Kleefstra N; van Hateren KJ
    J Diabetes Sci Technol; 2017 Mar; 11(2):438-439. PubMed ID: 27625346
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral hypoglycemic agents as an alternative therapy for gestational diabetes.
    Hod M; Shafrir E
    Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693
    [No Abstract]   [Full Text] [Related]  

  • 18. [The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study].
    Pan C; Gao Y; Gao X; Li G; Luo B; Shi H; Tian H; Jia P; Lin H; Xing X; Zhao Y; Zhou L
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):388-92. PubMed ID: 12137601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulfonylureas].
    Kobayashi K; Shimano H
    Nihon Rinsho; 2012 May; 70 Suppl 3():602-7. PubMed ID: 22768585
    [No Abstract]   [Full Text] [Related]  

  • 20. New Medications for the Treatment of Diabetes.
    Garg SK; Rewers AH; Akturk HK
    Diabetes Technol Ther; 2018 Feb; 20(S1):S139-S153. PubMed ID: 29437472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.